Molecular characterization of ofloxacin-resistant Mycobacterium tuberculosis strains from Russia.
about
New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutationsFrequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic reviewEarly detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.Polymorphisms associated with resistance and cross-resistance to aminoglycosides and capreomycin in Mycobacterium tuberculosis isolates from South Korean Patients with drug-resistant tuberculosis.Diagnostic Performance of the GenoType MTBDRplus and MTBDRsl Assays to Identify Tuberculosis Drug Resistance in Eastern China.First report of molecular detection of fluoroquinolone resistance-associated gyrA mutations in multidrug-resistant clinical Mycobacterium tuberculosis isolates in KuwaitEvaluation of the MTBDRsl test for detection of second-line-drug resistance in Mycobacterium tuberculosisIncidence of moxifloxacin resistance in clinical Mycobacterium tuberculosis isolates in Houston, Texas.Evaluation of two molecular assays for rapid detection of mycobacterium tuberculosis resistance to fluoroquinolones in high-tuberculosis and -multidrug-resistance SettingsMycobacterium tuberculosis gyrase inhibitors as a new class of antitubercular drugs.DNA gyrase inhibition assays are necessary to demonstrate fluoroquinolone resistance secondary to gyrB mutations in Mycobacterium tuberculosis.Comprehensive multicenter evaluation of a new line probe assay kit for identification of Mycobacterium species and detection of drug-resistant Mycobacterium tuberculosis.A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system.Extending the definition of the GyrB quinolone resistance-determining region in Mycobacterium tuberculosis DNA gyrase for assessing fluoroquinolone resistance in M. tuberculosis.Correlation between GyrA substitutions and ofloxacin, levofloxacin, and moxifloxacin cross-resistance in Mycobacterium tuberculosis.QSAR based therapeutic management of M. tuberculosis.Triplex real-time PCR melting curve analysis for detecting Mycobacterium tuberculosis mutations associated with resistance to second-line drugs in a single reaction.Correlation of different phenotypic drug susceptibility testing methods for four fluoroquinolones in Mycobacterium tuberculosis.Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China.Prevalence and genetic characterization of second-line drug-resistant and extensively drug-resistant Mycobacterium tuberculosis in Rural China.Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical IsolatesFeasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens.Sequence Analysis of Fluoroquinolone Resistance-Associated Genes gyrA and gyrB in Clinical Mycobacterium tuberculosis Isolates from Patients Suspected of Having Multidrug-Resistant Tuberculosis in New Delhi, India.Prevalence of fluoroquinolone resistance among tuberculosis patients in Shanghai, China.Beijing genotype of Mycobacterium tuberculosis is significantly associated with high-level fluoroquinolone resistance in Vietnam.A First Insight into the Genetic Diversity and Drug Susceptibility Pattern of Mycobacterium tuberculosis Complex in Zhejiang, China.Prevalence and molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis isolates in China.Proposal of a consensus set of hypervariable mycobacterial interspersed repetitive-unit-variable-number tandem-repeat loci for subtyping of Mycobacterium tuberculosis Beijing isolates.Specific gyrA gene mutations predict poor treatment outcome in MDR-TB.A novel resistance mutation in eccC5 of the ESX-5 secretion system confers ofloxacin resistance in Mycobacterium tuberculosis.Performance assessment of the GenoType MTBDRsl test and DNA sequencing for detection of second-line and ethambutol drug resistance among patients infected with multidrug-resistant Mycobacterium tuberculosis.Association of mutation patterns in gyrA/B genes and ofloxacin resistance levels in Mycobacterium tuberculosis isolates from East China in 2009.Gel-based microarrays in clinical diagnostics in Russia.Genotype MTBDRsl line probe assay shortens time to diagnosis of extensively drug-resistant tuberculosis in a high-throughput diagnostic laboratory.Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco.
P2860
Q28480855-045E7AC8-D3E2-4916-887A-6A4AD8889C7AQ28545095-E309F17C-ABB5-4A38-9D20-15795CF1AD2AQ33595707-DF20C36F-DE36-4E05-8AA9-15704AF607BAQ33627296-6A497BD0-FB93-42C0-BAA6-FD35BD610529Q33864689-F79F576B-7DA6-4C11-96FC-1026AB532AF8Q33872796-CC341025-994F-4D6F-A9F6-C2D4ACB77EABQ34046372-9F04D6B1-DD22-4E0E-BFE6-24E361980FC9Q35139691-D71A619A-C7F8-4117-96EE-559EA3EE1C9FQ35139804-5C73D270-1979-4FD1-BAB5-3A931848E7B9Q35169124-82E2964B-CB5B-448A-9644-0349F2B0C4A7Q35270379-DAC294D8-ADBA-4F1A-86EF-0C8133871BDAQ35807187-BFF3859F-7AE7-4ED9-8AAC-063D885733CCQ35821755-AB5BD102-64F1-455E-A435-421FCD513DA7Q35867476-42C1893C-A3C7-480A-AD17-0C34EA6C6FF6Q35960685-C05C7D6B-BFD5-453B-8253-1FD9FED9478BQ36359056-5CCEC3B6-0F1B-4475-B655-D55FDE3E84D9Q36762984-5FE88D61-44CF-42FF-9E78-30ABE1393492Q36794791-E470F504-36AB-4462-939A-443CF34616E1Q36875446-39230F74-56A7-45DF-8900-E8DBB82DF0C1Q37036485-DA186486-3B4E-4CAB-9B3C-18BF269BEE65Q37203798-06B921AB-E059-402A-8521-0B24F339A0F0Q37214096-44C5CF79-7F54-4602-9B61-8D0D1F35EBCAQ37218623-BACF5662-204E-4008-9749-BBAFB68CD8CBQ37247758-72D52048-87BB-4FDD-A677-B5444A34013AQ37409925-3A903705-BBAB-4CE0-A5E0-ED13296CB941Q37475592-8ADC46B8-FE3E-4526-B6E0-3C301FE67844Q37544551-4B55609A-60C8-4C86-905C-7160D7430615Q37546578-4A7F2735-B161-4283-BC0B-5BFD8BD5C3DFQ39398946-F7974DBF-6E58-4386-BB79-AB5229FE8193Q40645861-57F2136A-0E4B-4E8D-9287-67CF76048C44Q42141102-03954779-3088-4252-B8F0-C89664CCD1E6Q42224068-ECCBC9FA-F337-48B5-AA96-7E87402722F9Q43172450-876540E0-0EA0-4B24-97F1-691954D311FFQ50488873-488B5552-21E0-42E4-9379-7EE7F5F82EE6Q52682765-EBC5FBF3-E5EC-4858-9BA7-DD4DC14D5201
P2860
Molecular characterization of ofloxacin-resistant Mycobacterium tuberculosis strains from Russia.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Molecular characterization of ...... erculosis strains from Russia.
@en
type
label
Molecular characterization of ...... erculosis strains from Russia.
@en
prefLabel
Molecular characterization of ...... erculosis strains from Russia.
@en
P2093
P2860
P50
P356
P1476
Molecular characterization of ...... erculosis strains from Russia.
@en
P2093
Boris Vishnevsky
Tatiana Otten
Yulia Potapova
P2860
P304
P356
10.1128/AAC.00036-08
P407
P577
2008-06-16T00:00:00Z